Hellmut Samonigg

9.9k citations
118 papers · 6.7k · 2 hit papers · h-index 42

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 0.5%
    • Inflammatory Biomarkers in Disease Prognosis
    • Cancer Cells and Metastasis
    • HER2/EGFR in Cancer Research

Papers in

    • Inflammatory Biomarkers in Disease Prognosis 9
    • HER2/EGFR in Cancer Research 8
    • Cancer Treatment and Pharmacology 8
    • Cancer Cells and Metastasis 5
    • Breast Cancer Treatment Studies 14

Hellmut Samonigg

116 papers receiving 6.5k citations

Hellmut Samonigg's Hit Papers

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer 2013 · 415 citations
4150+7+14Years since publication200400600

Peers

Hellmut Samonigg
Comparison fields: 5 of 133
  • Cancer Research 2.3k
  • Oncology 3.3k
  • Genetics 886
  • Pathology and Forensic Medicine 434
  • Pulmonary and Respiratory Medicine 758
Replace Christoph Thomssen with:
Christoph Thomssen Germany
E. Kubista Austria
Eric Winquist Canada
Martin F. Fey Switzerland
Andrew Wardley United Kingdom
Luigi Dogliotti Italy
Philipp Harter Germany
N. J. O’Higgins Ireland
Maciej Krzakowski Poland
Anil Potti United States
Hellmut Samonigg relative to Christoph Thomssen Germany Christoph Thomssen's profile →
Citations per field
00.5×1.5×2.2×
Christoph Thomssen · 1×
Citations per year

Countries citing papers authored by Hellmut Samonigg

Since Specialization
Citations

This map shows the geographic impact of Hellmut Samonigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hellmut Samonigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hellmut Samonigg more than expected).

Fields of papers citing papers by Hellmut Samonigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hellmut Samonigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hellmut Samonigg. The network helps show where Hellmut Samonigg may publish in the future.

Co-authors

The 25 scholars most cited alongside Hellmut Samonigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hellmut Samonigg Line = papers co-authored together Hellmut Samonigg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Hit paper breakdown →
2005645
2
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Hit paper breakdown →
2013415
3 2013404
4
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
2002332
5 2008282
6 2003275
7 2013265
8 2004236
9 2002200
10 2006157
11 2011155
12 2006147
13 2005106
14 2004105
15 201494
16 200893
17 200590
18 201386
19 200984
20 201383

About Hellmut Samonigg

Hellmut Samonigg is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 118 papers that have together received 6.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers), Genetic factors in colorectal cancer (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (7 papers), Cancer Cells and Metastasis (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Cancer Research (2.3k citations), Oncology (3.3k citations), Genetics (886 citations), Pathology and Forensic Medicine (434 citations) and Pulmonary and Respiratory Medicine (758 citations). Hellmut Samonigg has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Armin Gerger, Michael Gnant, R. Jakesz, Martin Pichler, Peter Krippl, Thomas Bauernhofer, Wilfried Renner, Uwe Langsenlehner, W. Kwasny and Joanna Szkandera. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, PLoS ONE and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact